Asanuma et al. reported that high sPD-L1 levels are associated with a poor prognosis in soft tissue sarcomas, and their findings suggested that sPD-L1 is released by aggressive tumors [11]. This evidence concerns the gene SPDL1 and soft tissue sarcoma.